Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Cytograft Tissue Engineering Inc.
DescriptionAutologous tissue-engineered vascular graft
Molecular Target
Mechanism of Action 
Therapeutic ModalityCell therapy: Organ/tissue engineering
Latest Stage of DevelopmentPhase I/II
Standard Indication Renal (unspecified)
Indication DetailsTreat renal disease
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today